News and Insights
NAI Provides Guidance on Choosing a Chief Compliance Officer in Pharmaceutical Compliance Monitor
September 1, 2012
As pharmaceutical companies struggle to meet increasing legal and regulatory requirements, what’s really critical in a chief compliance officer? NAI Consultant Stephen Rothenberg, J.D., discusses the characteristics this executive should have in his article, Choosing the Right Chief Compliance Officer, published September 25, 2012 in Pharmaceutical Compliance Monitor. The article describes the key considerations for pharmaceutical companies in selecting a new head of compliance, and offers guidance for how these companies can best match candidate experience with their own needs.